These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7046378)

  • 21. Mutagenicity of non-K-region diols and diol-epoxides of benz(a)anthracene and benzo(a)pyrene in S. typhimurium TA 100.
    Malaveille C; Bartsch H; Grover PL; Sims P
    Biochem Biophys Res Commun; 1975 Sep; 66(2):693-700. PubMed ID: 1101891
    [No Abstract]   [Full Text] [Related]  

  • 22. Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides.
    Slaga TJ; Huberman E; Selkirk JK; Harvey RG; Bracken WM
    Cancer Res; 1978 Jun; 38(6):1699-704. PubMed ID: 647680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic activation of benz[alpha]anthracene in three biological systems.
    MacNicoll AD; Cooper CS; Ribeiro O; Pal K; Hewer A; Grover PL; Sims P
    Cancer Lett; 1981 Jan; 11(3):243-9. PubMed ID: 7248929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of 18 environmentally relevant polycyclic aromatic hydrocarbons and Clophen A50, as liver monooxygenase inducers, on the mutagenic activity of benz[a]anthracene in the Ames test.
    Norpoth K; Kemena A; Jacob J; Schümann C
    Carcinogenesis; 1984 Jun; 5(6):747-52. PubMed ID: 6426814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of metabolic activation of 7,12-dimethylbenz(a)anthracene in vitro by aroclor 1254-induced rat liver S-9 fraction.
    Bigger CA; Tomaszewski JE; Andrews AW; Dipple A
    Cancer Res; 1980 Mar; 40(3):655-61. PubMed ID: 6781743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of benz[a]anthracene by human liver microsomes.
    Sahali Y; Kidd LR; Skipper PL; Tannenbaum SR
    Cancer Lett; 1994 Aug; 83(1-2):299-303. PubMed ID: 8062227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences between products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin and in a rat liver microsomal system.
    Bigger CA; Tomaszewski JE; Dipple A
    Biochem Biophys Res Commun; 1978 Jan; 80(1):229-35. PubMed ID: 414751
    [No Abstract]   [Full Text] [Related]  

  • 30. Microsome-mediated mutagenicities of the dihydrodiols of 7,12-dimethylbenz[a]anthracene: high mutagenic activity of the 3,4-dihydrodiol.
    Malaveille C; Bartsch H; Tierney B; Grover PL; Sims P
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1468-73. PubMed ID: 100114
    [No Abstract]   [Full Text] [Related]  

  • 31. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vitro metabolic activation of dibenz[a,h]anthracene, catalyzed by by rat liver microsomes and examined by 32P-postlabelling.
    Lecoq S; Ni Shé M; Grover PL; Platt KL; Oesch F; Phillips DH
    Cancer Lett; 1991 May; 57(3):261-9. PubMed ID: 2032213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The involvement of a non-'bay-region' diol-epoxide in the formation of benz(a)anthracene-DNA adducts in a rat-liver microsomal system.
    MacNicoll AD; Cooper CS; Ribeiro O; Gervasi PG; Hewer A; Walsh C; Grover PL; Sims P
    Biochem Biophys Res Commun; 1979 Nov; 91(2):490-7. PubMed ID: 518647
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic activation of 7-ethyl- and 7-methylbenz[a]anthracene in mouse skin.
    McKay S; Phillips DH; Hewer AJ; Grover PL
    Carcinogenesis; 1988 Jan; 9(1):141-5. PubMed ID: 3335039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA binding as a probe for metabolic activation in various systems.
    Bigger CA; Dipple A
    Basic Life Sci; 1983; 24():587-604. PubMed ID: 6407468
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mechanism of the mutagenic action (in the Ames system) of polycyclic aromatic hydrocarbons].
    Kobliakov VA; Tolcheev IuD; Khitrovo IA
    Vestn Akad Med Nauk SSSR; 1984; (5):25-9. PubMed ID: 6377730
    [No Abstract]   [Full Text] [Related]  

  • 37. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
    Wood AW; Chang RL; Levin W; Kumar S; Shirai N; Jerina DM; Lehr RE; Conney AH
    Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of a diol-epoxide and a K-region epoxide with high efficiency by glutathione transferase X.
    Glatt H; Friedberg T; Grover PL; Sims P; Oesch F
    Cancer Res; 1983 Dec; 43(12 Pt 1):5713-7. PubMed ID: 6357430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships of quantum mechanical calculations, relative mutagenicity of benzo[a]anthracene diol epoxides, and "bay region" concept of aromatic hydrocarbon carcinogenicity.
    Lehr RE; Jerina DM
    J Toxicol Environ Health; 1977 Jul; 2(6):1259-65. PubMed ID: 328916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
    Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
    Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.